Edition:
United States

Allena Pharmaceuticals Inc (ALNA.OQ)

ALNA.OQ on NASDAQ Stock Exchange Global Select Market

14.25USD
12 Dec 2017
Change (% chg)

$-0.64 (-4.30%)
Prev Close
$14.89
Open
$14.77
Day's High
$14.98
Day's Low
$14.01
Volume
25,201
Avg. Vol
--
52-wk High
$15.40
52-wk Low
$8.66

Revenue & Earnings Per Share

 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 3 0.00 0.00 0.00 --
Quarter Ending Mar-18 2 0.00 0.00 0.00 --
Year Ending Dec-17 3 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-17 4 -0.32 -0.19 -0.41 --
Quarter Ending Mar-18 2 -0.32 -0.19 -0.44 --
Year Ending Dec-17 4 -1.63 -1.05 -2.33 --
Year Ending Dec-18 4 -1.34 -0.82 -1.89 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 185.97 35.27
P/E High - Last 5 Yrs. -- 274.53 45.26
P/E Low - Last 5 Yrs. -- 92.51 24.18
Beta -- 0.83 0.91
Price to Sales (TTM) -- 114.29 5.83
Price to Book (MRQ) -- 22.17 5.62
Price to Tangible Book (MRQ) 11.65 25.97 7.22
Price to Cash Flow (TTM) -- 101.40 24.19
% Owned Institutions 0.00 5.64 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.26 2.04
Dividend 5 Year Growth Rate -- 1.96 5.26
Payout Ratio(TTM) -- 96.00 46.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -3.18 6.84
Sales (TTM) vs TTM 1 Yr. Ago -- 30.07 5.66
Sales - 5 Yr. Growth Rate -- 33.24 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago 15.22 -149.23 7.22
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 43.30 10.92
Capital Spending - 5 Yr. Growth Rate -- 40.86 15.14

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.54
Current Ratio (MRQ) 9.19 5.74 3.56
LT Debt to Equity (MRQ) 28.67 14.43 13.40
Total Debt to Equity (MRQ) 36.59 16.88 19.46
Interest Coverage (TTM) -- -147.14 44.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.80 54.92
Gross Margin - 5 Yr. Avg. -- 55.48 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -218.62 15.49
Operating Margin (TTM) -- -632.11 6.65
Operating Margin - 5 Yr. Avg. -- -235.48 10.97
Pre-Tax Margin (TTM) -- -603.10 7.47
Pre-Tax Margin - 5 Yr. Avg. -- -235.80 11.38
Net Profit Margin (TTM) -- -600.62 3.70
Net Profit Margin - 5 Yr. Avg. -- -239.05 7.67
Effective Tax Rate (TTM) -- 15.26 24.26
Effective Tax Rate - 5 Yr. Avg. -- 18.70 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 21,614,065 848,695,288
Net Income/Employee (TTM) -839,185 -1,754,114 99,009,570
Receivable Turnover (TTM) -- 25.64 6.11
Inventory Turnover (TTM) -- 2.61 3.55
Asset Turnover (TTM) -- 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -9.38 11.28
Return on Assets - 5 Yr. Avg. -- 0.11 12.25
Return on Investment (TTM) -- -11.84 14.40
Return on Investment - 5 Yr. Avg. -- 3.18 16.04
Return on Equity (TTM) -- -36.93 15.99
Return on Equity - 5 Yr. Avg. -- 5.57 17.25
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -72.01 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Allena Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 19.12 15.75 86 96
13 Week -- -- -- 71
26 Week -- -- -- 68
52 Week -- -- -- 59
YTD -- -- -- 47
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 17.84%
# of Holders: 2
Total Shares Held: 3,677,964
3 Mo. Net Change: 3,677,964
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 0
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.